Current Recommendations and Future Prospects in the Treatment of Toxoplasmosis
- 1 December 1989
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 38 (6), 973-987
- https://doi.org/10.2165/00003495-198938060-00008
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Trimethoprim-Sulfamethoxazole Desensitization in the Acquired Immunodeficiency SyndromeAnnals of Internal Medicine, 1987
- Activity of roxithromycin against Toxoplasma gondii in murine modelsJournal of Antimicrobial Chemotherapy, 1987
- Potent in Vivo Activity of Arprinocid, a Purine Analogue, Against Murine ToxoplasmosisThe Journal of Infectious Diseases, 1986
- Interferon-γ suppresses the growth of Toxoplasma gondii in human fibroblasts through starvation for tryptophanMolecular and Biochemical Parasitology, 1986
- Toxoplasmosis. Problems in diagnosis and treatmentCancer, 1983
- Toxoplasma gondii infection of the central nervous systemHuman Pathology, 1981
- Development of Adverse Sequelae in Children Born with Subclinical Congenital Toxoplasma InfectionPediatrics, 1980
- Treatment of Ocular Toxoplasmosis with Clindamycin and SulfadiazineOphthalmology, 1980
- Value of Lymph-Node Biopsy in the Diagnosis of Acute Acquired ToxoplasmosisNew England Journal of Medicine, 1973
- Therapy of Toxoplasmosis UveitisAmerican Journal of Ophthalmology, 1965